The Dexcom G6 Continuous Glucose Monitoring (CGM) System can be used with both connected insulin pumps and pens,* allowing for more choice in your diabetes management.
An Urgent Low Soon alert can warn you of serious hypoglycemia, giving you greater peace of mind.
Tap into a network of like-minded people who share their experiences to inspire others living with diabetes, and those new to using Dexcom CGM.
-We know how valuable your time is. Make insulin dosing decisions in 2 hours†,4 10 hours sooner than Freestyle Libre.
-No fingersticks‡ needed!
-Dexcom CGM ranks #1 in patient satisfaction.
-Dexcom G6 users are 3x more satisfied with their CGM system than Libre users.§
‡If your glucose alerts and readings from Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
"Making the jump to Dexcom G6 from the FreeStyle Libre 2 was the best decision I made for my diabetes management. With the ability to check my glucose levels from my smartphone|| and share my data with my spouse,¶, #my A1C has never been better.”
Stephanie Weaver, age 27,
Type 1 diabetes
"I used the Freestyle Libre 2 for over a year. It had many wrong readings, so my endocrinologist recommended I use Dexcom G6. I liked that I could use my Phone|| and receiver at the same time. Not needing to scan the device is far more convenient for me.”
Richard Benson, age 63,
Type 2 diabetes
Dexcom G6 steps up where other CGM systems fall short
BENEFITS OF CGM |
DEXCOM G64 |
ABBOTT FREESTYLE LIBRE 25 |
ABBOTT FREESTYLE LIBRE 36 |
Both zero fingersticks‡ and zero scanning |
✓ |
- |
✓ |
Sends readings automatically to your dedicated receiver without scanning |
✓ |
- |
- |
Ability to constantly see glucose values on your smart watch**,†† |
✓ |
- |
- |
Customizable alerts and readings delivered without scanning |
✓ |
- |
✓ |
Automatic predictive low alert |
✓ |
- |
- |
Compatible with automated insulin delivery systems |
✓ |
- |
- |
No vitamin C accuracy interference |
✓ |
- |
- |
Wear length |
10 days |
14 days |
14 days |
Full-term sensor survival rate |
94% |
71% |
68% |
Time before making diabetes treatment decisions, including the dosing of insulin |
2 hours |
12 hours + confirmatory fingersticks |
12 hours + confirmatory fingersticks |
Indicated for ages 2 years+ |
✓ |
- |
- |
Dedicated receiver available |
✓ |
✓ |
- |
‡ If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
**Compatible Smart device required to view CGM data on smart watch.
It is available at pharmacies nationwide, and you may find better coverage through pharmacy benefits (a prescription is required).
*To learn more about insulin pump integrations and compatibility with Dexcom G6, visit dexcom.com/g6/integrations-and-compatibility. †Use your meter when making a treatment decision during warmup. §Based on NPS Score Dexcom 81 vs. Abbott 27. Comparison of NPS scores of Dexcom, Abbott, and Medtronic, Seagrove Survey 2021 Patient Perspectives. ||For a list of compatible devices, visit dexcom.com/compatibility ¶Separate Follow app and internet connection required. Users should always confirm readings on the Dexcom G6 app or receiver before making treatment decisions. #Followers must have compatible smart devices to use the Dexcom Follow app: Dexcom.com/compatibility. **Compatible smart device required to view CGM data on smart watch. ††Libre 3 will only send alert notifications. ‡‡Preferred to recommend Dexcom to patients with type 1 or type 2 diabetes on mealtime insulin over Abbott FreeStyle Libre, Medtronic, and Senseonics sensors. §§Healthcare providers can register for Dexcom Clarity at clarity.dexcom.com/professional/registration. ¶¶An internet connection is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com/compatibility. Healthcare providers will only be able to view a patient’s glucose data if the patient elects to share it with them through Dexcom Clarity. ##Refers to the estimated out-of-pocket cost for eligible commercially insured patients for the Dexcom G6 sensor and transmitter when claims are adjudicated as a pharmacy benefit, and includes benefits and offerings through available Dexcom programs, such as the voucher program. Actual cost may vary and is subject to individual insurance coverage.
1 Seagrove Healthcare Provider Survey Q1 2021. 65. 2 dQ&A US Q1 2021 Diabetes Connections Patient Panel Report. 69-72.
3 Abbott FreeStyle Libre 14-Day System User’s Guide, US, 2018. 4 Dexcom G6 CGM System User Guide, 2020. 5 Abbott Freestyle Libre 2 Flash Glucose Monitoring System User’s Manual, US, 2020. 6 FreeStyle Libre 3 User’s Manual. 2022. 7 Dexcom, data on file, 2020. 8 Seagrove Partners Q3 2020 Patient Perspectives Survey. 2020: 36. 9 Centers for Medicare & Medicaid Services, Medicare Coverage of Diabetes Supplies, Services, & Prevention Programs. 2019; 6. 10 dQ&A Endocrinologist Perspectives, Q4 2019 Summary Report. 2019: 24. 11 Seagrove Partners. Customer Survey, August 2019: 21. 12 Dexcom, data on file, 2020.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https:// www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.